We Offer a Curated Platform
For Market Entry And
Major Growth Opportunity
Governments in the region urgently need to introduce new and effective solutions to combat the growing prevalence of chronic and inherited disease otherwise the economic burden that they impose could reach up to $68 billion annually by 2022. (Alpen Capital) Africa though not without it’s challenges provides other plentiful opportunities in the primary healthcare sector, which the International Finance Corporation (IFC) estimates is worth $35bn.
Over the past two decades Africa has emerged from a troubled history to become one of the world’s fastest growing economic regions…Africa GDP $2.4 trillion in 2013 and expected to climb to $3.3 trillion by 2020 is already on par with Russia. Estimates indicate the African pharmaceutical market will be worth between $40 billion and $60 billion by 2020. (The rise of the African consumer, McKinsey & Company October 2012)
Our Services
Market Access
Increase your market reach. We help you align your growth strategies with the needs of the local population to solve key health concerns.
Regulatory
Make us your partner of choice. We will register and license your FDA and EMA European approved products in throughout the Middle East Markets.
Sales and Distribution
We deliver strategies tailored to the local market to increase sales and distribution of your products. Our plans and capabilities deliver results.
Healthcare Investment Advisory
We actively identify funding sources for healthcare and pharmaceutical companies. Focusing on those interested in
capitalizing growth opportunities in the Middle East and African healthcare market(s).
Market Access and Network
Our customers benefit from our vast network of regional stakeholders such as, but not limited to, health authorities, hospitals, clinics, payors and patients. Our vast network also includes regional distributors within MENA with strong expertise, capabilities, market leading positions and close ties to local stakeholders.
One of the main characteristics that differentiates Dubai from other commercial centers is its openness to innovation and the freedoms it grants people and institutions to operate. Abdul Aziz Al Ghurair
CREATING OPPORTUNITIES
Professionally Curated Health Innovation Platform For MEA
Strategy
Market Assessment
- Identify and prioritize target markets
- Market size and potential
- Risks and opportunities
Market Entry Strategy
- Competitive market profile
- Competitive landscape
- Patient flow
- Distribution channels
Market Access
- Price waterfall
- Regulatory Assessment and Support
- Payers and Reimbursement
Business Development
Distribution Agreements
- Local business partner screening & evaluation
- Business cases
- Negotiation strategy and deal structure
- Negotiation of deal term sheets and distribution agreements
Global Licensing, M&A and Technology Transfers Capital & Fund Raising
Distribution Management
- Regional Market & Distributors Coordination
- Marketing and Sales
- Regional Representative Office
- Legal entity set-up/Sponsorship
News & Events
JP Morgan Health 2018
2018 BIO Int’l Convention
